Treatment practices for aspirin-exacerbated respiratory disease: analysis of a national insurance claims database.

Abstract

BACKGROUND:

Aspirin-exacerbated respiratory disease (AERD) is the triad of asthma, nasal polyposis, and sensitivity to cyclooxygenase-1 inhibitors. Treatment options include medical management, surgical intervention, and aspirin desensitization (AsaD).

METHODS:

AERD patients were identified using the MarketScan Database from 2009 to 2015. Patients were included using International Classification of Diseases, 9th edition (ICD-9) codes for asthma, nasal polyposis, and drug allergy. Treatments were determined by Current Procedural Terminology (CPT) codes for drug desensitization and endonasal procedures. Geographic trends and timing of interventions between those exposed and not exposed to desensitization were explored.

RESULTS:

A total of 5628 patients met inclusion criteria for AERD, with mean age 46 years, 60% female; 395 (7%) underwent AsaD and 2171 (39%) underwent sinus surgery. Among patients who were desensitized, 229 (58%) underwent surgery, of whom 201 (88%) had surgery prior to AsaD (median [quartile 1, quartile 3]; 61 days [30, 208] prior to desensitization). For patients undergoing surgery following AsaD (n = 46), surgery was performed a median of 302 (163, 758) days after AsaD. Nineteen patients had multiple surgeries post-AsaD with median time between surgeries being 734 days (312, 1484); 261 patients were not desensitized to aspirin but did undergo multiple surgeries, with the median of the median time between surgeries being 287 days (15, 617), which is shorter than for patients post-AsaD (p < 0.001).

CONCLUSION:

A very small percentage of AERD patients undergo AsaD. Patients who had AsaD underwent surgery approximately 2 months prior to AsaD. Patients who underwent AsaD experienced an increased time between surgeries compared to patients who did not undergo AsaD.

• Authors: Lauren T Roland, Celeste Nagy, Heqiong Wang, Renee Moore, Katherine N Cahill, Tanya M Laidlaw, Sarah K Wise, John M DelGaudio, Merin Kuruvilla, Joshua M Levy
• Journal: International forum of allergy & rhinology (Int Forum Allergy Rhinol) Vol. 10 Issue 2 Pg. 190-193 (02 2020) ISSN: 2042-6984 [Electronic] United States
• PMID: 31693796 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
• Copyright: © 2019 ARS-AAOA, LLC.

Topics

• Adult
• Asthma, Aspirin-Induced (therapy)
• Databases, Factual
• Desensitization, Immunologic
• Female
• Humans
• Male
• Middle Aged
• Nasal Polyps (therapy)
• National Health Insurance, United States
• United States